Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy

DOI: 10.1080/2162402X.2016.1221555

Keywords: DNA methylation, PD-1, PDCD1, prognostic biomarker, prostate cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text